| Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation ME Figueroa, O Abdel-Wahab, C Lu, PS Ward, J Patel, A Shih, Y Li, ... Cancer cell 18 (6), 553-567, 2010 | 3219 | 2010 |
| MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts T Thum, C Gross, J Fiedler, T Fischer, S Kissler, M Bussen, P Galuppo, ... Nature 456 (7224), 980-984, 2008 | 2934 | 2008 |
| Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia A Melnick, JD Licht Blood, The Journal of the American Society of Hematology 93 (10), 3167-3215, 1999 | 1388 | 1999 |
| Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling LA Sena, S Li, A Jairaman, M Prakriya, T Ezponda, DA Hildeman, ... Immunity 38 (2), 225-236, 2013 | 1377 | 2013 |
| Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia M Tartaglia, CM Niemeyer, A Fragale, X Song, J Buechner, A Jung, ... Nature genetics 34 (2), 148-150, 2003 | 1227 | 2003 |
| EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation W Béguelin, R Popovic, M Teater, Y Jiang, KL Bunting, M Rosen, H Shen, ... Cancer cell 23 (5), 677-692, 2013 | 983 | 2013 |
| Transcription factors, normal myeloid development, and leukemia DG Tenen, R Hromas, JD Licht, DE Zhang Blood, The Journal of the American Society of Hematology 90 (2), 489-519, 1997 | 980 | 1997 |
| Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl K Somasundaram, H Zhang, YX Zeng, Y Houvras, Y Peng, H Zhang, ... Nature 389 (6647), 187-190, 1997 | 706 | 1997 |
| Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? RW Johnstone, JD Licht Cancer cell 4 (1), 13-18, 2003 | 622 | 2003 |
| Sprouty proteins: multifaceted negative-feedback regulators of receptor tyrosine kinase signaling JM Mason, DJ Morrison, MA Basson, JD Licht Trends in cell biology 16 (1), 45-54, 2006 | 496 | 2006 |
| Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11; 17) JD Licht, C Chomienne, A Goy, A Chen, AA Scott, DR Head, JL Michaux, ... | 439 | 1995 |
| The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t (4; 14) multiple myeloma cells E Martinez-Garcia, R Popovic, DJ Min, SMM Sweet, PM Thomas, ... Blood, The Journal of the American Society of Hematology 117 (1), 211-220, 2011 | 430 | 2011 |
| MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation ME Figueroa, L Skrabanek, Y Li, A Jiemjit, TE Fandy, E Paietta, ... Blood, The Journal of the American Society of Hematology 114 (16), 3448-3458, 2009 | 413 | 2009 |
| Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction MA Basson, S Akbulut, J Watson-Johnson, R Simon, TJ Carroll, R Shakya, ... Developmental cell 8 (2), 229-239, 2005 | 406 | 2005 |
| Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells JM Polo, T Dell'Oso, SM Ranuncolo, L Cerchietti, D Beck, GF Da Silva, ... Nature medicine 10 (12), 1329-1335, 2004 | 363 | 2004 |
| Sprouty1 regulates reversible quiescence of a self-renewing adult muscle stem cell pool during regeneration KL Shea, W Xiang, VS LaPorta, JD Licht, C Keller, MA Basson, AS Brack Cell stem cell 6 (2), 117-129, 2010 | 358 | 2010 |
| Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain KF Ahmad, A Melnick, S Lax, D Bouchard, J Liu, CL Kiang, S Mayer, ... Molecular cell 12 (6), 1551-1564, 2003 | 343 | 2003 |
| The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling LB Sullivan, E Martinez-Garcia, H Nguyen, AR Mullen, E Dufour, ... Molecular cell 51 (2), 236-248, 2013 | 330 | 2013 |
| Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation I Gross, B Bassit, M Benezra, JD Licht Journal of Biological Chemistry 276 (49), 46460-46468, 2001 | 322 | 2001 |
| Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies TE Fandy, JG Herman, P Kerns, A Jiemjit, EA Sugar, SH Choi, AS Yang, ... Blood, The Journal of the American Society of Hematology 114 (13), 2764-2773, 2009 | 315 | 2009 |
Ari MelnickProfessor of Medicine, Weill Cornell MedicineEmail verificata su med.cornell.edu